LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

Search

Abbott Laboratories

Fermé

SecteurSoins de santé

129.13 0.34

Résumé

Variation du prix de l'action

24h

Actuel

Min

128.86

Max

129.35

Chiffres clés

By Trading Economics

Revenu

-135M

1.6B

Ventes

227M

11B

P/E

Moyenne du Secteur

15.979

79.874

BPA

1.3

Rendement du dividende

1.84

Marge bénéficiaire

14.46

Employés

114,000

EBITDA

-33M

3B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+14.55% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.84%

2.31%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-7.3B

221B

Ouverture précédente

128.79

Clôture précédente

129.13

Sentiment de l'Actualité

By Acuity

25%

75%

55 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Abbott Laboratories Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

20 nov. 2025, 13:14 UTC

Acquisitions, Fusions, Rachats

Correction to Abbott to Acquire Exact Sciences for $21 Billion Article

20 nov. 2025, 13:11 UTC

Acquisitions, Fusions, Rachats

Abbott to Acquire Exact Sciences for $21 Billion -- Update

20 nov. 2025, 12:55 UTC

Acquisitions, Fusions, Rachats

Abbott to Acquire Exact Sciences for $21 Billion

20 nov. 2025, 21:23 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

20 nov. 2025, 16:51 UTC

Acquisitions, Fusions, Rachats

Abbott Laboratories Will Buy Cologuard Maker Exact Sciences for $21 Billion -- Barrons.com

20 nov. 2025, 15:08 UTC

Acquisitions, Fusions, Rachats

Abbott to Acquire Exact Sciences for $21 Billion -- 4th Update

20 nov. 2025, 14:39 UTC

Market Talk
Acquisitions, Fusions, Rachats

Abbott and Exact Sciences Should Make a Good Fit -- Market Talk

20 nov. 2025, 14:30 UTC

Market Talk
Acquisitions, Fusions, Rachats

Exact Sciences Should Give Abbott's Diagnostics Business a Needed Boost -- Market Talk

20 nov. 2025, 13:54 UTC

Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Palo Alto Networks, Alphabet, and More -- Barrons.com

20 nov. 2025, 13:51 UTC

Acquisitions, Fusions, Rachats

Abbott to Acquire Exact Sciences for $21 Billion -- 3rd Update

20 nov. 2025, 13:25 UTC

Acquisitions, Fusions, Rachats

Abbott to Acquire Exact Sciences for $21 Billion -- 2nd Update

20 nov. 2025, 13:24 UTC

Acquisitions, Fusions, Rachats

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion. -- Barrons.com

20 nov. 2025, 12:59 UTC

Acquisitions, Fusions, Rachats

Correction to Abbott to Acquire Exact Sciences for $21B Article

20 nov. 2025, 12:58 UTC

Acquisitions, Fusions, Rachats

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion. -- Barrons.com

20 nov. 2025, 12:56 UTC

Acquisitions, Fusions, Rachats

Abbott to Acquire Exact Sciences for $21B -- Update

20 nov. 2025, 12:54 UTC

Acquisitions, Fusions, Rachats

Abbott Labs: Expect to Maintain Investment-Grade Credit Rating >ABT EXAS

20 nov. 2025, 12:53 UTC

Acquisitions, Fusions, Rachats

Abbott Labs to Fund Exact Sciences Deal With Cash on Hand, Debt Financing >ABT EXAS

20 nov. 2025, 12:53 UTC

Acquisitions, Fusions, Rachats

Abbott Labs Sees Exact Sciences Deal Adding to Adjusted EPS in 2028, Beyond >ABT EXAS

20 nov. 2025, 12:53 UTC

Acquisitions, Fusions, Rachats

Abbott Labs Sees Exact Sciences Deal Cutting Adjusted EPS by 20c in 2026, 16c in 2027 >ABT EXAS

20 nov. 2025, 12:52 UTC

Acquisitions, Fusions, Rachats

Abbott Labs Sees at Least $100 Million Annual Pretax Synergies From Exact Sciences Deal by 2028 >ABT EXAS

20 nov. 2025, 12:46 UTC

Acquisitions, Fusions, Rachats

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion. -- Barrons.com

20 nov. 2025, 12:40 UTC

Acquisitions, Fusions, Rachats

Abbott to Acquire Exact Sciences for $21B

20 nov. 2025, 12:33 UTC

Acquisitions, Fusions, Rachats

Abbott Labs: Exact Sciences Deal Has Enterprise Value of About $23 Billion >ABT EXAS

20 nov. 2025, 12:33 UTC

Acquisitions, Fusions, Rachats

Exact Sciences to Be Acquired for $105/Share; Closed Wednesday at $86.18 >ABT EXAS

20 nov. 2025, 12:32 UTC

Acquisitions, Fusions, Rachats

Abbott Labs Sees Acquisition Immediately Adding to Revenue Growth, Gross Margin >ABT EXAS

20 nov. 2025, 12:31 UTC

Acquisitions, Fusions, Rachats

Abbott Labs: Exact Sciences Deal Has Total Equity Value of About $21 Billion >ABT EXAS

20 nov. 2025, 12:30 UTC

Acquisitions, Fusions, Rachats

Abbott to Buy Exact Sciences for $105/Share >ABT EXAS

20 nov. 2025, 12:30 UTC

Acquisitions, Fusions, Rachats

Abbott To Acquire Exact Sciences, A Leader In Large And Fast-growing Cancer Screening And Precision Oncology Diagnostics Segments >ABT

19 nov. 2025, 21:27 UTC

Acquisitions, Fusions, Rachats

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

30 oct. 2025, 12:38 UTC

Résultats

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

Comparaison

Variation de prix

Abbott Laboratories prévision

Objectif de Prix

By TipRanks

14.55% hausse

Prévisions sur 12 Mois

Moyen 147.24 USD  14.55%

Haut 162 USD

Bas 136 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

19 ratings

17

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

132.82 / 134.43Support & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Neutral Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

55 / 374Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat